Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance

Only a subset of cancer patients respond to T-cell checkpoint inhibitors, highlighting the need for alternative immunotherapeutics. We performed CRISPR-Cas9 screens in a leukemia cell line to identify perturbations that enhance natural killer effector functions. Our screens defined critical componen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pech, Matthew F, Fong, Linda E, Villalta, Jacqueline E, Chan, Leanne JG, Kharbanda, Samir, O'Brien, Jonathon J, McAllister, Fiona E, Firestone, Ari J, Jan, Calvin H, Settleman, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713475/
https://www.ncbi.nlm.nih.gov/pubmed/31452512
http://dx.doi.org/10.7554/eLife.47362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713475/
https://www.ncbi.nlm.nih.gov/pubmed/31452512
http://dx.doi.org/10.7554/eLife.47362

Ejemplares similares